Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Advanced Gastric Adenocarcinoma × spartalizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1 Sarcoma 1 Osteosarcoma 1 Gastrointestinal Stromal Tumors 1 Desmoplastic Small Round Cell Tumor 1 Chondrosarcoma 1 Bone Neoplasms 1 Advanced Solid Tumor 1 Advanced Gastric Adenocarcinoma 1

Interventions

camrelizumab 2 spartalizumab 1 apatinib 1 S 1 (combination) 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04174339 2019-11-22

PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric Cancer

Fujian Cancer Hospital

Phase NA Unknown

Gastrointestinal

Advanced Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡